Specialist fields (in extracts)
- hematology
- malignant blood diseases
- autologous stem cell transplantation
- palliative care
Curriculum vitae (in extracts)
| 01.04.2022 |
Chief Physician, Clinic for Hematology, Helios Hospital Bad Saarow |
| 01.09.2019 | Head of the Hematology Section, Clinic for Hematology, Oncology and Palliative Medicine, Helios Hospital Bad Saarow |
| Since 01.09.2014 |
Senior physician, Clinic for Hematology, Oncology and Palliative Medicine, Helios Hospital Bad Saarow |
| 01.08.2009-31.08.2014 |
Senior physician, Clinic for Hematology, Oncology and Tumor Immunology, Helios Hospital Berlin Buch |
| 01.01.2002-31.08.2009 |
Resident, Clinic for Hematology, Oncology and Tumor Immunology, Helios Hospital Berlin Buch |
Academic Experience
| 01.11.2016
|
Master of Business Administration in Health Care Management, HWR Berlin
|
| 10.02.2016
|
Specialist in Internal Medicine, Hematology and Oncology
|
| 23.02.2011
|
Additional qualification in palliative medicine
|
| 14.09.2009
|
Doctorate in Medicine, Humboldt University, Berlin
|
| 19.01.2009
|
Specialist in Internal Medicine
|
| 01.07.2003
|
License to practice medicine
|
| 30.01.2001
|
Medical examination
|
| 1994-2001
|
Study of human medicine, Free University and Humboldt University, Berlin Practical year: Surgery Florence/ Italy, Internal Medicine Genoa/ Italy and Berlin Erasmus exchange: Stockholm/ Sweden |
| 09/1992-11/1993
|
Civilian service as paramedic at the rescue service of the district Plön
|
Contributions
Publications
- Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG. (Leukemia. 2014 May;28(5):1001-7. doi: 10.1038/leu.2013.297. Epub 2013 Oct 22.); PMID: 24150216
- Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients. (Ann Hematol. 2012 Jul;91(7):1051-63. doi: 10.1007/s00277-012-1423-4. Epub 2012 Feb 24.); PMID: 22362118
-
Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes. (Lancet. 2010 Dec 11;376(9757):2000-8. doi: 10.1016/S0140-6736(10)62105-8.); PMID: 21131036
-
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG. (Leukemia. 2009 Dec;23(12):2248-58. doi: 10.1038/leu.2009.183. Epub 2009 Sep 10.); PMID: 19741727
Memberships
- German Society for Hematology and Oncology
- German Society for Internal Medicine
- European Hematology Association
Send Request
We speak Arabic, English, French, German and Russian
